Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/11/2025 ,inter alia, to consider and approve the unaudited financial results ....

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sarda Proteins Ltd has informed BSE that its Board meeting, originally scheduled for November 26, 2025, has been postponed to November 29, 2025. The Board will consider and approve the unaudited financial results for the half year and quarter ended September 30, 2025. The trading window for dealing in the company's securities remains closed and will reopen 48 hours after the outcome of the meeting is announced. Signed by Managing Director Khilan Savaliya.

Likely market impact

This is a procedural update with no direct impact on shareholders or stock price. Investors should watch for the actual financial results expected after November 29, 2025 for any meaningful signals on company performance.